Identification of novel markers for monitoring minimal residual disease in acute lymphoblastic leukemia
Jiann-Shiuh Chen(St. Jude Children's Research Hospital), Dario Campana(National University of Singapore), Ching‐Hon Pui(St. Jude Children's Research Hospital), Keichiro Mihara, Toshio Suzuki(St. Jude Children's Research Hospital), Elaine Coustan‐Smith(St. Jude Children's Research Hospital), Geoffrey Neale(St. Jude Children's Research Hospital)
Cited by 173
Related Papers
International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data
|Blood|2022|2.8k
Treatment of Acute Lymphoblastic Leukemia
|New England Journal of Medicine|2006|2k
Classification, subtype discovery, and prediction of outcome in pediatric acute lymphoblastic leukemia by gene expression profiling
|Cancer Cell|2002|1.9k
HIF1α–dependent glycolytic pathway orchestrates a metabolic checkpoint for the differentiation of TH17 and Treg cells
|The Journal of Experimental Medicine|2011|1.8k